section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: rash

GI: liver enzymes, cholecystitis, cholelithiasis, nausea, pancreatitis

MS: myopathy, RHABDOMYOLYSIS

Misc: ANGIOEDEMA

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Renal Impairment

US Brand Names

Zetia

Action

  • Inhibits absorption of cholesterol in the small intestine.
Therapeutic effects:
  • Reduction of LDL-C concentrations.
  • Reduction of sitosterol and campesterol concentrations.

Classifications

Therapeutic Classification: lipid-lowering agents

Pharmacologic Classification: cholesterol absorption inhibitors

Pharmacokinetics

Absorption: Following absorption, rapidly converted to ezetimibe-glucuronide, which is active. Bioavailability is variable.

Distribution: Unknown.

Metabolism/Excretion: Undergoes enterohepatic recycling, mostly eliminated in feces, minimal renal excretion.

Half-Life: 22 hr.

Canadian Brand Names

Ezetrol

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown

Patient/Family Teaching

Pronunciation

e-ZET-i-mibe

Pill Image

ezetimibe_195-8834.jpg

Code

NDC Code